Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man.

Abstract

British Journal of Clinical PharmacologyVolume 15, Issue 1 p. 21-29 Free Access Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man. DP Nicholls, DP NichollsSearch for more papers by this authorDW Harron, DW HarronSearch for more papers by this authorRG Shanks, RG ShanksSearch for more papers by this author DP Nicholls, DP NichollsSearch for more papers by this authorDW Harron, DW HarronSearch for more papers by this authorRG Shanks, RG ShanksSearch for more papers by this author First published: January 1983 https://doi.org/10.1111/j.1365-2125.1983.tb01458.xCitations: 9AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References BARBAT, J., WARRINGTON, S.J., WEERASURIYA, K. & PATEL, L. (1981). Effect of hydralazine on systolic time intervals. Br. J. clin. Pharmac., 11, 117P– 118P. BRUNNER, H., HEDWALL, P.R. & MEIER, M. (1967). Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine. Br. J. Pharmac. Chemother., 30, 123– 133. DAVIES, I.B., SEVER, P.S. & ROSENTHAL, T. (1979). Sympathetic reflex responses during treatment of essential hypertension with hydralazine and oxprenolol. Br. J. clin. Pharmac., 8, 49– 51. FREIS, E.D. & FINNERTY, F.A. JR. (1950). Suppression of vasomotor reflexes in man following 1-hydrazinophthalozine (C-5968). Proc. Soc. exp. Biol. Med., 75, 23– 24. GERSHWIN, M.E. & SMITH, T. (1967). Mode of action of hydralazine on guinea pig atria. Arch. int. Pharmacodyn. Ther., 170, 108– 116. GLICK, G. & BRAUNWALD, E. (1965) Relative roles of the sympathetic and parasympathetic nervous systems in the reflex control of heart rate. Circ. Res., 16, 363– 375. HARRON, D.W.G. ARNDTS, D. & SHANKS, R.G. (1982b). Alinidine pharmacokinetics following acute and chronic dosing. Br. J. clin. Pharmac., 13, 821– 827. HARRON, D.W.G., JADY, K., RIDDELL, J.G. & SHANKS, R.G. (1982a). Effects of alinidine, a novel bradycardic agent, on heart rate and blood pressure in man. J. cardiovasc. Pharmac., 4, 213– 220. HARRON, D.W.G., RIDDELL, J.G. & SHANKS, R.G. (1981). Alinidine reduces heart-rate without blockade of beta-adrenoceptors. Lancet, i, 351– 353. KHATRI, I., UEMURA, N., NOTARGIACOMO, A. & FREIS, E.D. (1977). Direct and reflex cardiostimulating effects of hydralazine. Am. J. Cardiol., 40, 38– 42. KOBINGER, W., LILLIE, C. & PICHLER, L. (1979a). N-allylderivative of clonidine a substance with specific bradycardie action at a cardiac site. Naunyn-Schmiedeberg's Arch. Pharmac., 306, 255– 262. KOBINGER, W., LILLIE, C. & PICHLER, L. (1979b). Cardiovascular actions of Af-allyl-clonidine (ST567), a substance with specific bradycardie action. Eur. J. Pharmac., 58, 141– 150. KOCH-WESER, J. (1974). Myocardial inactivity of therapeutic concentrations of hydralazine and diazoxide. Experientia, 30, 170– 171. KOCH-WESER, J. (1976). Drug Therapy: hydralazine. New Engl. J. Med., 295, 320– 323. TVELD, MANIN A.J., WENTING, G.J., BOOMSMA, F., VERHOEVEN, R.P. & SCHALEKAMP, M.A.D.H. (1980). Sympathetic and parasympathetic components of reflex cardiostimulation during vasodilator treatment of hypertension. Br. J. clin. Pharmac., 9, 547– 551. MILLAR, J.S. & WILLIAMS, VAUGHAN E.M. (1981). Anion antagonism — a fifth class of antiarrhythmic action Lancet, i, 1291– 1292. MROCZEK, W.J., LEE, W.R., DAVIDOV, M.E. & FINNERTY, F.A. (1976). Vasodilator administration in the presence of beta-adrenergic blockade. Circulation, 53, 985– 988. O'MALLEY, K., VELASCO, M., WELLS, J. & McNAY, J. (1976). Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent—minoxidil. Eur. J. clin. Pharmac., 9, 355– 360. PICKERING, T.G., GRIBBIN, B., PETERSEN, E.S., CUNNINGHAM, D.J.C. & SLEIGHT, P. (1972). Effects of autonomic blockade on the baroreflex in man at rest and during exercise. Circ. Res., 30, 177– 185. ROBINSON, B.F., EPSTEIN, S.E., BEISER, G.D. & BRAUNWALD, E. (1966). Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ. Res., 19, 400– 411. SANNERSTEDT, R., STENBERG, J., JOHNSSON, G. & WERKO, L. (1971). Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Am. J. Cardiol., 28, 316– 320. VELASCO, M., ROMERO, E., BERTONCINI, H., URBINAQUINTANA, A., GUEVARA, J. & HERNANDEZPIERETTI, O. (1978). Effect of propranolol on sympathetic nervous activity in hydralazine-treated hypertensive patients. Br. J. clin. Pharmac., 6, 217– 220. WENDLING, M.G., DE GRAAF, G.L. & Du CHARME, D.W. (1979). The effects of sympatholytics, angiotensin and vasopressin on the cardiovascular response to minoxidil or hydralazine in conscious dogs. Clin. exp. Hypertension, 1, 521– 537. WRIGHT, B.M. & DORE, C.F. (1970). A random zero sphygmomanometer. Lancet, i, 337– 338. ZACEST, R., GILMORE, E. & KOCH-WESER, J. (1972). Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade. New Engl. J. Med., 286, 617– 622. Citing Literature Volume15, Issue1January 1983Pages 21-29 ReferencesRelatedInformation